Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 1/2020

01-01-2020 | Metastasis | Peritoneal Surface Malignancy

Defining and Refining the Role for Surgery and Intraperitoneal Chemotherapy in the Treatment of Peritoneal Surface Malignancies

Authors: M. Haroon Choudry, MD, David L. Bartlett, MD, H. Richard Alexander, MD, Kiran K. Turaga, MD

Published in: Annals of Surgical Oncology | Issue 1/2020

Login to get access

Excerpt

The 14th Annual International Symposium on Regional Cancer Therapies (2019) took place in Phoenix Arizona, under the auspices of the Society of Surgical Oncology. Once again, this meeting was a tremendous success and provided another opportunity for education, thoughtful discourse, scientific collaboration, and innovation. In this educational series, we highlight some of the recent preclinical and clinical research focused on regional therapies for metastatic cancers. …
Literature
1.
2.
3.
Baratti D, Kusamura S, Azmi N, et al. Colorectal peritoneal metastases treated by perioperative systemic chemotherapy and cytoreductive surgery with or without mitomycin-C-based HIPEC. A comparative study using the peritoneal surface disease severity score (PSDSS). Ann Surg Oncol. 2019 (in press).
4.
5.
6.
7.
8.
9.
10.
11.
12.
Zambrano-Vera K, Sardi A, Munoz-Zuluaga C, et al. Outcomes in peritoneal carcinomatosis from appendiceal goblet cell carcinoma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC). Ann Surg Oncol. 2019 (in press).
13.
Narayan RR, Harris JW, Chou JF, et al. Prediction of recurrence patterns from hepatic parenchymal disease after resection of colorectal liver metastases. Ann Surg Oncol. 2019 (in press).
14.
Metadata
Title
Defining and Refining the Role for Surgery and Intraperitoneal Chemotherapy in the Treatment of Peritoneal Surface Malignancies
Authors
M. Haroon Choudry, MD
David L. Bartlett, MD
H. Richard Alexander, MD
Kiran K. Turaga, MD
Publication date
01-01-2020
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 1/2020
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-019-07956-x

Other articles of this Issue 1/2020

Annals of Surgical Oncology 1/2020 Go to the issue

Peritoneal Surface Malignancy

Diaphragmatic Peritoneal Stripping Versus Full-Thickness Resection in CRS/HIPEC: Is There a Difference?

Health Services Research and Global Oncology

Introducing: The Landmark Series

Gastrointestinal Oncology

Surveillance of Low-Grade Appendiceal Mucinous Neoplasms With Peritoneal Metastases After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Are 5 Years Enough? A Multisite Experience

Peritoneal Surface Malignancy

Shorter Survival of Patients with Upper-Third Gastric Cancer Preoperatively Diagnosed as Stage IA Compared with Those with Middle to Lower Lesions

ASO Author Reflections

ASO Author Reflections: Using the Gastric Cancer Peritoneal Carcinomatosis Risk Score to Inform Surveillance and Treatment

Peritoneal Surface Malignancy

Desmoplastic Small Round Cell Tumor: Long-Term Complications After Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy